MENU
CRLBF
AS OF
Feb 3 closing price
Price
$1.06
Change
-$0.35 (-24.82%)
Capitalization
376.33M
42 days until earnings call
Intraday BUY SELL Signals
+Compare
CRLBF
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$1.06
Change
-$0.35 (-24.82%)
Capitalization
376.33M

CRLBF Cresco Labs Inc. Forecast, Technical & Fundamental Analysis

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others... Show more

CRLBF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CRLBF with price predictions
Feb 02, 2026

Momentum Indicator for CRLBF turns negative, indicating new downward trend

CRLBF saw its Momentum Indicator move below the 0 level on January 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CRLBF turned negative on January 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

CRLBF moved below its 50-day moving average on January 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRLBF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRLBF broke above its upper Bollinger Band on January 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRLBF advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 80 cases where CRLBF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRLBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.884) is normal, around the industry mean (29.772). P/E Ratio (0.000) is within average values for comparable stocks, (74.035). CRLBF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.041). CRLBF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (0.557) is also within normal values, averaging (112.501).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRLBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CRLBF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRLBF is expected to report earnings to fall 64.80% to -1 cents per share on March 18

Cresco Labs Inc. CRLBF Stock Earnings Reports
Q4'25
Est.
$-0.02
Q3'25
Missed
by $0.02
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on November 05 showed earnings per share of -5 cents, missing the estimate of -2 cents. With 731.53K shares outstanding, the current market capitalization sits at 376.33M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
400 West Erie Street
Phone
+1 312 319-8442
Employees
3200
Web
https://www.crescolabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAUAX5.260.08
+1.54%
Gabelli Utilities A
HOOYX30.870.07
+0.23%
Hartford Schroders US Small Cap Opps Y
VSPVX464.190.10
+0.02%
Vanguard S&P 500 Value Index Instl
POICX9.97-0.11
-1.09%
Virtus Tactical Allocation C
RYFAX90.18-1.00
-1.10%
Rydex Financial Services H

CRLBF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+1.92%
TSNDF - CRLBF
76%
Closely correlated
+6.96%
CURLF - CRLBF
76%
Closely correlated
+5.99%
TCNNF - CRLBF
75%
Closely correlated
-0.48%
JUSHF - CRLBF
74%
Closely correlated
+1.43%
GTBIF - CRLBF
72%
Closely correlated
-0.30%
More

Groups containing CRLBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+1.92%
Pharmaceuticals: Generic
industry (214 stocks)
28%
Poorly correlated
+48.62%